These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 25325795)
1. Targeted delivery of anticancer agents via a dual function nanocarrier with an interfacial drug-interactive motif. Zhang X; Huang Y; Zhao W; Liu H; Marquez R; Lu J; Zhang P; Zhang Y; Li J; Gao X; Venkataramanan R; Xu L; Li S Biomacromolecules; 2014 Nov; 15(11):4326-35. PubMed ID: 25325795 [TBL] [Abstract][Full Text] [Related]
2. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel. Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124 [TBL] [Abstract][Full Text] [Related]
3. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel. Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577 [TBL] [Abstract][Full Text] [Related]
4. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093 [TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550 [TBL] [Abstract][Full Text] [Related]
6. An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance. Lu J; Zhao W; Liu H; Marquez R; Huang Y; Zhang Y; Li J; Xie W; Venkataramanan R; Xu L; Li S J Control Release; 2014 Dec; 196():272-86. PubMed ID: 25456831 [TBL] [Abstract][Full Text] [Related]
7. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel. Zhang X; Huang Y; Zhao W; Chen Y; Zhang P; Li J; Venkataramanan R; Li S Mol Pharm; 2014 Aug; 11(8):2807-14. PubMed ID: 24987803 [TBL] [Abstract][Full Text] [Related]
8. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267 [TBL] [Abstract][Full Text] [Related]
9. Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier. Zhai Q; Chen Y; Xu J; Huang Y; Sun J; Liu Y; Zhang X; Li S; Tang S Mol Pharm; 2017 Nov; 14(11):3888-3895. PubMed ID: 28850241 [TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier. Zhang P; Lu J; Huang Y; Zhao W; Zhang Y; Zhang X; Li J; Venkataramanan R; Gao X; Li S AAPS J; 2014 Jan; 16(1):114-24. PubMed ID: 24281690 [TBL] [Abstract][Full Text] [Related]
11. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Lu J; Huang Y; Zhao W; Marquez RT; Meng X; Li J; Gao X; Venkataramanan R; Wang Z; Li S Biomaterials; 2013 Feb; 34(5):1591-600. PubMed ID: 23182923 [TBL] [Abstract][Full Text] [Related]
12. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel. Zhang P; Huang Y; Liu H; Marquez RT; Lu J; Zhao W; Zhang X; Gao X; Li J; Venkataramanan R; Xu L; Li S Biomaterials; 2014 Aug; 35(25):7146-56. PubMed ID: 24856103 [TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer. Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661 [TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer. Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816 [TBL] [Abstract][Full Text] [Related]
15. Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy. Zhang P; Li J; Ghazwani M; Zhao W; Huang Y; Zhang X; Venkataramanan R; Li S Biomaterials; 2015 Oct; 67():104-14. PubMed ID: 26210177 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related]
17. Mixed micelles of TPGS and Soluplus Wang Y; Ding Y; Xu Y; Wang C; Ding Y; Gao M; Ma C; Ma X; Li L Pharm Dev Technol; 2020 Sep; 25(7):865-873. PubMed ID: 32266855 [TBL] [Abstract][Full Text] [Related]
18. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery. Chen D; Yu H; Sun K; Liu W; Wang H Drug Deliv; 2014 Jun; 21(4):258-64. PubMed ID: 24102086 [TBL] [Abstract][Full Text] [Related]
19. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818 [TBL] [Abstract][Full Text] [Related]
20. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]